Skip to main content
logo
AstraZeneca PLC (LON:AZN)
London flag London · Delayed Price · Currency is GBP · Price in GBX
12,006
-140 (-1.15%)
Sep 4, 2026, 5:15 PM GMT

AstraZeneca Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
4,8935,7115,4885,8406,1666,329
Short-Term Investments
75---6453
Trading Asset Securities
-837201416
Cash & Short-Term Investments
4,9685,7195,5255,8606,2446,398
Cash Growth
-30.11%3.51%-5.72%-6.15%-2.41%-20.37%
Accounts Receivable
14,33010,2378,3028,4077,2126,031
Other Receivables
1,6594,0644,7923,5282,7112,764
Receivables
15,98914,30113,09411,9359,9238,795
Inventory
6,9326,5575,2885,4244,6998,983
Prepaid Expenses
-2,0341,7371,6171,3291,512
Restricted Cash
-22129102162-
Other Current Assets
769054116236556
Total Current Assets
27,96528,72325,82725,05422,59326,244
Property, Plant & Equipment
16,30014,70311,64710,5029,44910,171
Long-Term Investments
2,9162,5251,9001,6771,1421,262
Goodwill
21,18121,24221,02520,04819,82019,997
Other Intangible Assets
37,72337,84637,17738,08939,30742,387
Long-Term Deferred Tax Assets
6,4875,8195,3474,7183,2634,330
Other Long-Term Assets
3,2613,2161,1121,031909972
Total Assets
115,833114,074104,035101,11996,483105,363

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
22,8933,8203,6403,2672,5502,824
Accrued Expenses
-19,29916,08815,84513,51412,358
Short-Term Debt
2,949644330515350411
Current Portion of Long-Term Debt
2,9672,5412,0575,6035,9242,248
Current Portion of Leases
426382339271228233
Current Income Taxes Payable
1,4681,0841,4061,584896916
Current Unearned Revenue
-1441261491821,181
Other Current Liabilities
8502,7033,8803,3082,6492,423
Total Current Liabilities
31,55330,61727,86630,54226,29322,594
Long-Term Debt
23,68624,71526,62122,40323,90829,717
Long-Term Leases
2,3221,4211,113857725754
Long-Term Unearned Revenue
-55-71426
Pension & Post-Retirement Benefits
8521,1051,3301,5201,1682,454
Long-Term Deferred Tax Liabilities
3,4633,5003,3052,8442,9446,206
Other Long-Term Liabilities
3,5873,9422,9293,7804,3734,325
Total Liabilities
65,46365,35563,16461,95359,42566,076

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
388388388388387387
Additional Paid-In Capital
35,28235,26635,22635,18835,15535,126
Retained Earnings
12,59212,5997,2294,5163,1203,644
Comprehensive Income & Other
2,033414-2,057-949-1,625111
Total Common Equity
50,29548,66740,78639,14337,03739,268
Minority Interest
755285232119
Shareholders' Equity
50,37048,71940,87139,16637,05839,287
Total Liabilities & Equity
115,833114,074104,035101,11996,483105,363

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
32,35029,70330,46029,64931,13533,363
Net Cash (Debt)
-27,382-23,984-24,935-23,789-24,891-26,965
Net Cash Growth
------
Net Cash Per Share
-17.52-15.35-15.95-15.23-15.96-18.90
Filing Date Shares Outstanding
1,5511,5511,5511,5501,5501,549
Total Common Shares Outstanding
1,5511,5511,5511,5501,5501,549
Working Capital
-3,588-1,894-2,039-5,488-3,7003,650
Book Value Per Share
32.4331.3826.3025.2523.9025.34
Tangible Book Value
-8,609-10,421-17,416-18,994-22,090-23,116
Tangible Book Value Per Share
-5.55-6.72-11.23-12.25-14.25-14.92
Land
-7,2406,5806,4695,4406,377
Machinery
-10,3208,8548,7047,5567,903
Construction In Progress
-4,7402,7892,0452,6532,728